Fluency® Endovascular Stent Graft FEM09100Recalls & reported problems
Bard Peripheral Vascular, Inc. · FLUENCY® PLUS Endovascular Stent Graft 9 mm x 100 mm (80 cm delivery system) · Class 3 · Implant
All models of Fluency Endovascular Stent Graft (51)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 04049519008561), received between May 18, 2016 and Dec 4, 2025 — classified as 5 malfunctions.
The most frequently reported specific device problem is “Fracture” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Fracture3
- Positioning Failure3
- Material Perforation2
- Misfire2
- Device Damaged by Another Device1
- Use of Device Problem1
Patient problems
- No Consequences Or Impact To Patient4
- No Clinical Signs, Symptoms or Conditions1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 4, 2025Misfire; Misfire
A PATIENT UNDERWENT STENT GRAFT PLACEMENT PROCEDURE USING FLUENCY STENT GRAFT. DURING PROCEDURE, THE STENT PARTIAL DEPLOYED. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23714961 ↗MalfunctionOct 15, 2019Positioning Failure; Fracture; Misfire; Positioning Failure; Fracture; Misfire
THIS REPORT SUMMARIZES ONE MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL FEM09100. ENDOVASCULAR STENT GRAFT ALLEGEDLY EXPERIENCED FAILURE TO DEPLOY, MISFIRE, AND FRACTURE. THIS REPORT WAS RECEIVED FROM A SINGLE SOURCE. THIS REPORT WAS RECEIVED FROM A SINGLE SOURCE. THIS EVENT DID INVOLVE PATIENT WITH NO REPORTED PATIENT INJURY. THE PATIENT IS 66 YEARS OLD, MALE AND 59KGS.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9192287 ↗MalfunctionNov 1, 2017Fracture; Use of Device Problem; Device Damaged by Another Device; Fracture; Use of Device Problem; Device Damaged by Another Device
IT WAS REPORTED THAT A STENT GRAFT WAS SUCCESSFULLY PLACED IN THE BASILIC VEIN. APPROXIMATELY ONE MONTH AFTER STENT GRAFT PLACEMENT DURING DIALYSIS TREATMENT. THE DIALYSIS NEEDLE HAD CAUGHT ONTO THE STENT DURING RETRACTION OF THE NEEDLES, AND ALLEGEDLY PULLED OUT A FRAGMENT OF THE STENT GRAFT THROUGH THE BASILIC VEIN AND THE PATIENT'S SKIN. REPORTEDLY, THE ACCESS SITE WAS TIGHT AND THERE WAS RESISTANCE DURING REMOVAL OF THE NEEDLES AND STENT FRAGMENT. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6994237 ↗MalfunctionOct 3, 2017Positioning Failure; Fracture; Material Perforation; Positioning Failure; Fracture; Material Perforation
IT WAS REPORTED THAT DURING DEPLOYMENT, USING THE PIN AND PULL PROCESS, THE ENDOVASCULAR STENT GRAFT ALLEGEDLY ONLY PARTIALLY DEPLOYED AS THERE WAS NO MORE ROOM BETWEEN THE CATHETER AND THE HANDLE TO CONTINUE WITH THE PIN & PULL ACTION IN ORDER TO FULLY DEPLOY THE STENT GRAFT. THEREFORE, THE DELIVERY SYSTEM WAS REMOVED WITH THE PARTIAL DEPLOYED STENT WITHOUT INCIDENT. REPORTEDLY, ANOTHER DELIVERY SYSTEM WAS USED IN ORDER TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6909466 ↗MalfunctionMay 18, 2016Positioning Failure; Material Perforation; Material Perforation
IT WAS REPORTED THAT THE ENDOVASCULAR STENT GRAFT COULD NOT BE DEPLOYED. ANOTHER ENDOVASCULAR STENT GRAFT WAS USED TO COMPLETE THE PROCEDURE SUCCESSFULLY. NO COMPLICATIONS WERE CAUSED. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 5665292 ↗
Other System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment devices
- COVERA AVSM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall33 reports
- COVERA AVSM08060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall21 reports
- COVERA AVSM09060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall18 reports
- COVERA AVSM10080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall16 reports
- COVERA AVSM10040Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall15 reports
- COVERA AVFM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall14 reports
- COVERA AVSM09080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall1 death14 reports
- COVERA AVSM10100Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall13 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page